Asia-Pacific Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Asia-Pacific biotechnology market had total revenues of $249.9 billion in 2021, representing a compound annual growth rate (CAGR) of 15.2% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $126.5 billion, equivalent to 50.6% of the market's overall value.
- The Indian market is the largest in the Asia-Pacific region, accounting for 38% of its total value in 2021. The Indian market has experienced some of the strongest growth rates in the region in recent years, as it develops in maturity.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Asia-Pacific
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific biotechnology market with five year forecasts by both value and volume
- What was the size of the Asia-Pacific biotechnology market by value in 2021?
- What will be the size of the Asia-Pacific biotechnology market in 2026?
- What factors are affecting the strength of competition in the Asia-Pacific biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in Asia-Pacific's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of leading players?
- 7.4. What has been the rationale behind recent M&A activity?
- 8 Company Profiles
- 8.1. Takeda Pharmaceutical Company Limited
- 8.2. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- 8.3. Shanghai Kehua Bio-engineering Co Ltd
- 8.4. Astellas Pharma Inc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
- Table 2: Asia–Pacific biotechnology industry category segmentation: % share, by value, 2016–2021
- Table 3: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
- Table 4: Asia–Pacific biotechnology industry geography segmentation: $ billion, 2021
- Table 5: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
- Table 6: Takeda Pharmaceutical Company Limited: key facts
- Table 7: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
- Table 8: Takeda Pharmaceutical Company Limited: Key Employees
- Table 9: Takeda Pharmaceutical Company Limited: Key Employees Continued
- Table 10: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts
- Table 11: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Annual Financial Ratios
- Table 12: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: Key Employees
- Table 13: Shanghai Kehua Bio-engineering Co Ltd: key facts
- Table 14: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
- Table 15: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
- Table 16: Astellas Pharma Inc.: key facts
- Table 17: Astellas Pharma Inc.: Annual Financial Ratios
- Table 18: Astellas Pharma Inc.: Key Employees
- Table 19: Astellas Pharma Inc.: Key Employees Continued
- Table 20: Asia-Pacific exchange rate, 2017–21
- List of Figures
- Figure 1: Asia-Pacific biotechnology industry value: $ billion, 2016–21
- Figure 2: Asia-Pacific biotechnology industry category segmentation: $ billion, 2016-2021
- Figure 3: Asia–Pacific biotechnology industry geography segmentation: % share, by value, 2021
- Figure 4: Asia-Pacific biotechnology industry value forecast: $ billion, 2021–26
- Figure 5: Forces driving competition in the biotechnology industry in Asia-Pacific, 2021
- Figure 6: Drivers of buyer power in the biotechnology industry in Asia-Pacific, 2021
- Figure 7: Drivers of supplier power in the biotechnology industry in Asia-Pacific, 2021
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Asia-Pacific, 2021
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Asia-Pacific, 2021
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Asia-Pacific, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook